Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project)
Procedures/Professional Services (Temporary Codes)
G9092 is a valid 2024 HCPCS code for Oncology; disease status; rectal cancer, limited to invasive cancer, adenocarcinoma as predominant cell type; extent of disease initially established as t1-3, n1-2, m0 (prior to neo-adjuvant therapy, if any) with no evidence of disease progression, recurrence or metastases (for use in a medicare-approved demonstration project) or just “Onc dx rectal t1-3,n1-2noprg” for short, used in Medical care.
HCPCS Level II Code Procedures/Professional Services (Temporary Codes) |
|
HCPCS Code | G9092 |
---|---|
Description |
Long description:
Short description: |
HCPCS Modifier1 | |
HCPCS Pricing indicator |
00 - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
|
Multiple pricing indicator |
9 - Not applicable as HCPCS not priced separately by part B or value is not established
|
Coverage code | C - Carrier judgment |
BETOS2 code | P7B - Oncology - other |
HCPCS Action code | N - No maintenance for this code |
Type of service | 1 - Medical care |
Effective date | Effective Jan 01, 2007 |
Date added | Added Jan 01, 2006 |
HCPCS Coding Procedures |
In HCPCS Level II, modifiers are composed of two alpha or alphanumeric characters.
Example: E0260-NU - Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress
“NU” identifies the hospital bed as new equipment
1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).
2 BETOS stands for “Berenson-Eggers Type Of Service”